Skip to main content
Caplight Logo









StemRad

StemRad

Private
Tel AvivFrontier & Industrial Techhttps://stemrad.com/

Last Round

Series C

Dec 4, 2017

Total Funding Raised

$6M

Company Overview

StemRad is a personal protective equipment company that develops and manufactures selective radiation shielding for first responders, military personnel, medical teams, and astronauts.

Sector

Frontier & Industrial Tech

Verticals

Medical Devices, Defense Tech, Space Technology, Medical Imaging

Business Model

B2G

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

radiation protectionwearable radiation shieldselective shieldingpersonal protective equipmentPPEradiation geargamma radiation shielddefense techbone marrow protectionspace technologyAcute Radiation SyndromeARSfirst responder equipmentmedical devicesnuclear safety equipmentexoskeleton

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StemRad Comparables

Compare StemRad with similar companies based on industry and business-model similarity.

StemRad comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rampart IC
71%
TIDI Products
70%
Salus Scientific
62%

StemRad Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 4, 2017

Key People

Founding team and executive leadership

Oren Milstein

CEO And Chief Scientific Officer

Executive Team

StemRad Investors

Notable investors and investment history

StemRad investors
InvestorRounds
Drs. Kiran & Pallavi Patel Family OfficeVC Round
Wanaka Capital PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 58% MoM.

  • Jun 1, 2025

    Monthly visitors increased 72% MoM, reaching 9.8K.

StemRad Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

StemRad Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about StemRad's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range12
Year Founded2011
Last FundingDec 4, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?